Recombinant factor VIII concentrates

Seminars in Thrombosis and Hemostasis
M Franchini, Giuseppe Lippi

Abstract

The development and introduction of recombinant factor VIII (rFVIII) concentrates nearly 20 years ago represented a major advance in the treatment of hemophilia A patients. Currently, first-, second- and third-generation rFVIII products are commercially available. Whereas first-generation rFVIII concentrates are stabilized with human albumin, second-generation rFVIII products contain sucrose instead of albumin in the final formulation. Finally, third-generation rFVIII products are manufactured without additional human or animal plasma proteins. The use of rFVIII concentrates has greatly improved the safety of replacement therapy in hemophilia A and virtually abolished the risk of blood-borne pathogen transmission. The remaining and most challenging aspect of hemophilia A management has now become the development of FVIII inhibitors. In this article we review the current knowledge on the commercially available rFVIII concentrates, analyzing their main characteristics. Moreover, results of the literature on their clinical hemostatic efficacy and safety are summarized.

Citations

May 4, 2012·Orphanet Journal of Rare Diseases·Massimo Franchini, Pier Mannuccio Mannucci
Apr 23, 2013·Italian Journal of Pediatrics·Paola GiordanoAngelo Claudio Molinari
Jun 13, 2014·Blood Transfusion = Trasfusione Del Sangue·Antonio CoppolaGiovanni Di Minno
Nov 8, 2013·Journal of Thrombosis and Thrombolysis·Min XuanRenchi Yang
Mar 21, 2012·Expert Opinion on Biological Therapy·Emmanuel J FavaloroGiuseppe Lippi
May 19, 2011·Annals of Medicine·Giuseppe LippiEmmanuel J Favaloro
Jan 26, 2016·Acta Pharmacologica Sinica·Ruo-lan GuGui-fang Dou
Jun 4, 2015·Thrombosis Research·Stefan SchmidbauerStefan Schulte
Dec 4, 2015·Thrombosis and Haemostasis·H Marijke van den BergUNKNOWN PedNet Study group
Jun 18, 2015·Scientific Reports·Daniela DalmSvetla Stoilova-McPhie
Nov 9, 2010·Air Medical Journal·Peter Tilney
Feb 23, 2020·Journal of Thrombosis and Haemostasis : JTH·Rosella FamàAntonia Follenzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

© 2021 Meta ULC. All rights reserved